Cytek Biosciences (CTKB) Income from Non-Controlling Interests (2021 - 2023)
Cytek Biosciences' (CTKB) quarterly Income from Non-Controlling Interests came in at $235000.0 in Q4 2023, up 24.34% YoY from $189000.0 in Q4 2022, and up 200.0% on a QoQ basis from -$235000.0 in Q1 2023.
Cytek Biosciences (CTKB) Income from Non-Controlling Interests (2021 - 2023) Analysis & Trends
Cytek Biosciences (CTKB) has 3 years of Income from Non-Controlling Interests data on file, last reported at $235000.0 in Q4 2023.
- Quarterly Income from Non-Controlling Interests rose 24.34% year-over-year to $235000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $189000.0 (up 62.93% YoY) and the FY2022 annual result came in at -$92000.0, down 453.85% from the prior year.
- Income from Non-Controlling Interests improved to $235000.0 in Q4 2023, from -$235000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $315000.0 in Q1 2021 to a low of -$235000.0 in Q1 2023.
- A 3-year average of $57125.0 and a median of $65000.0 in 2021 frame the typical range for Income from Non-Controlling Interests.
- The widest YoY moves for Income from Non-Controlling Interests: up 626.92% in 2022, down 143.49% in 2022.
- Tracing CTKB's Income from Non-Controlling Interests over 3 years: stood at $26000.0 in 2021, then jumped by 626.92% to $189000.0 in 2022, then advanced by 24.34% to $235000.0 in 2023.
- The last three Income from Non-Controlling Interests figures came in at $235000.0 (Q4 2023), -$235000.0 (Q1 2023), and $189000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 900,000.00 |
| 10 | Cytek Biosciences | 609.76 Mn | 535.91 Mn | 28.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 235,000.00 |
| Mar 31, 2023 | -235,000.00 |
| Dec 31, 2022 | 189,000.00 |
| Sep 30, 2022 | -40,000.00 |
| Jun 30, 2022 | 104,000.00 |
| Mar 31, 2022 | -137,000.00 |
| Dec 31, 2021 | 26,000.00 |
| Mar 31, 2021 | 315,000.00 |